0001965301-23-000120.txt : 20230908 0001965301-23-000120.hdr.sgml : 20230908 20230908165818 ACCESSION NUMBER: 0001965301-23-000120 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 231245944 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Venker Eric CENTRAL INDEX KEY: 0001801917 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ROIVANT SCIENCES, INC. STREET 2: 320 WEST 37TH STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 144 1 primary_doc.xml 144 0001801917 XXXXXXXX LIVE 0001635088 Roivant Sciences Ltd. 001-40782 CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950 Venker Eric Officer Common Rockefeller Financial LLC

45 Rockefeller Plaza - Floor 5 New York NY 10111

106430 1297505.36 771742197 09/08/2023 NASDAQ Common 09/08/2023 Options Exercise - Grant Date 4/20/2022 Roivant Sciences Ltd. N 106430 09/08/2023 Wire N Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common 06/09/2023 299384 2967299.96 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common 06/22/2023 15882 158978.82 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

common 07/20/2023 159387 1802034.65 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common 07/21/2023 181998 2025358.44 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common 07/21/2023 28937 322068.81 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common shares 07/24/2023 16297 179104.03 Eric Venker

c/o Roivant Sciences Ltd. 7th Floo 50 Broadway London X0 SW1H 0DB

Common Shares 07/24/2023 33081 361645.23 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common shares 07/25/2023 28344 307869.19 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

common shares 07/26/2023 28344 307869.19 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

common shares 07/27/2023 23622 259448.15 Erik Venker

c/o Roivant Sciences Ltd. 7th Floor, 50 London, X0 X0 SW1H 0D

Common 07/31/2023 117372 1397752.56 Erik Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

Common Shares 08/01/2023 61397 732070.41 erik Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

common 08/02/2023 16397 194421.65 erik Venker

/o Roivant Sciences Ltd. 7th Floor, 50 Broadway7th Floor, 50 Broa London X0 SW1H 0DB

common 08/03/2023 44629 532317.84 erik Venker

/o Roivant Sciences Lt 7th Floor, 50 London X0 SW1H 0DB

common 08/14/2023 59811 711028.49 erik Venker

c/o Roivant Sciences Ltd 7th Floor, 50 Broadway London X0 SW1H 0DB

common 08/22/2023 16105 174417.15 erik Venker

c/o Roivant Sciences Ltd 7th Floor, 50 Broadway London X0 SW1H 0DB

common 09/01/2023 14763 175612.86 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

common 09/05/2023 73275 873311.45 Eric Venker

c/o Roivant Sciences Ltd. 7th Floor 50 Broadway London X0 SW1H 0DB

common 09/08/2023 5926 70233.61 The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/25/2023. 09/08/2023 02/25/2023 Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker